Top-Thema

19.09.18
ROUNDUP/Aktien New York Schluss: Dow und S&P 500 nähern sich ihren Rekordhochs

Altria Reports 2018 Second-Quarter and First-Half Results; Tightens 2018 Full-Year Earnings Guidance

Donnerstag, 26.07.2018 13:05



RICHMOND, Va. --(BUSINESS WIRE)--

Altria Group, Inc. (Altria) (NYSE: MO) today announced its 2018 second-quarter and first-half business results and tightened its guidance for 2018 full-year adjusted diluted earnings per share (EPS).

“We continued our strong start to the year with adjusted diluted earnings per share growth of 18.8% in the second quarter. Our core tobacco businesses performed well as they continued to make strategic investments in support of their long-term objectives. Of course, our results benefited from a lower corporate tax rate,” said Howard Willard, Altria’s Chairman and Chief Executive Officer. “We continued to reward shareholders in the quarter by paying out over $1.3 billion in dividends and repurchasing approximately $437 million in shares.”

“To reflect a strong first half and continued confidence in our core tobacco businesses, we are raising the lower-end of our guidance and now expect full-year adjusted diluted EPS growth of 16% to 19%.”

As previously announced, a conference call with the investment community and news media will be webcast on July 26, 2018 at 9:00 a.m. Eastern Time. Access to the webcast is available at www.altria.com/webcasts and via the Altria Investor app.

Altria Headline Financials1

           
($ in millions, except per share data)   Q2 2018   Change vs.

Q2 2017

      First Half 2018   Change vs.

First Half 2017

Net revenues   $6,305   (5.4)%       $12,413   (2.6)%
Revenues net of excise taxes   $4,879   (3.7)%       $9,549   (1.1)%
Tax rate:
Reported tax rate   26.6%   (5.0) pp       24.9%   (7.3) pp
Adjusted tax rate   22.9%   (12.6) pp       23.1%   (12.5) pp
Per share data:
Reported diluted EPS   $0.99   (3.9)%       $1.99   13.7%
Adjusted diluted EPS   $1.01   18.8%       $1.96   24.1%

1 “Adjusted” financial measures presented in this release exclude the impact of special items. See “Basis of Presentation” for more information.

Cash Returns to Shareholders

Dividends:

  • Altria paid over $1.3 billion in dividends in the second quarter.
  • Altria’s current annualized dividend rate is $2.80 per share, representing an annualized dividend yield of 4.9% as of July 20, 2018.
  • Altria expects to maintain a dividend payout ratio target of approximately 80% of adjusted diluted EPS. Future dividend payments remain subject to the discretion of Altria’s Board of Directors (Board).

Share Repurchase Program:

  • Altria repurchased 7.6 million shares in the second quarter at an average price of $57.65, for a cost of approximately $437 million.
  • In May 2018, the Board authorized a $1 billion expansion to the previous $1 billion share repurchase program.
  • As of June 30, 2018, Altria had slightly more than $1 billion remaining in the current $2 billion share repurchase program, which Altria expects to complete by the end of the second quarter of 2019. The timing of share repurchases depends upon marketplace conditions and other factors, and this program remains subject to the discretion of the Board.

Innovation

In pursuit of Altria’s aspiration to be the U.S. leader in authorized, non-combustible, reduced-risk products:

  • In May, Altria announced a new corporate structure to accelerate its innovation pipeline and maximize its core tobacco businesses.
  • USSTC submitted premarket tobacco product applications to the U.S. Food and Drug Administration (FDA) for VERVE Discs and VERVE Chews.
  • Nu Mark grew e-vapor volume by approximately 16% in the quarter, reflecting its expansion of MarkTen Elite to over 23,000 retail stores.
  • PM USA’s initial lead market plans for IQOS are ready to deploy upon FDA authorization.

Other Notable Events

  • In July, Altria submitted its comments for the three advance notices of proposed rulemaking (ANPRM) that were published by the FDA in the first quarter. The comments are available at www.altria.com.

2018 Full-Year Guidance

Altria tightens its guidance for 2018 full-year adjusted diluted EPS to be in a range of $3.94 to $4.03, representing a growth rate of 16% to 19% from an adjusted diluted EPS base of $3.39 in 2017 as shown in Schedule 10. This guidance range excludes the special items for the first half of 2018 shown in Table 1 and an additional $0.05 of tax expense resulting from the Tax Cuts and Jobs Act (Tax Reform Act) expected in the second half of 2018. This tax expense is related to a tax basis adjustment to Altria’s AB InBev investment. Altria’s 2018 guidance reflects investments in focus areas for long-term growth, including innovative product development and launches, regulatory science, brand equity, retail fixtures and future retail concepts.

Altria expects its 2018 full-year adjusted effective tax rate will be in a range of approximately 23% to 24%.

Altria’s full-year adjusted diluted EPS guidance and full-year forecast for its adjusted effective tax rate exclude the impact of certain income and expense items that management believes are not part of underlying operations. These items may include, for example, loss on early extinguishment of debt, restructuring charges, gain/loss on AB InBev/SABMiller business combination, AB InBev special items, certain tax items, charges associated with tobacco and health litigation items, and resolutions of certain non-participating manufacturer (NPM) adjustment disputes under the Master Settlement Agreement (such dispute resolutions are referred to as NPM Adjustment Items).

Altria’s management cannot estimate on a forward-looking basis the impact of certain income and expense items, including those items noted in the preceding paragraph, on its reported diluted EPS and its reported effective tax rate because these items, which could be significant, may be infrequent, are difficult to predict and may be highly variable. As a result, Altria does not provide a corresponding U.S. generally accepted accounting principles (GAAP) measure for, or reconciliation to, its adjusted diluted EPS guidance or its adjusted effective tax rate forecast.

The factors described in the “Forward-Looking and Cautionary Statements” section of this release represent continuing risks to Altria’s forecast.

ALTRIA GROUP, INC.

See "Basis of Presentation" for an explanation of financial measures and reporting segments discussed in this release. Altria uses the equity method of accounting for its investment in AB InBev and reports its share of AB InBev’s results using a one-quarter lag.

Financial Performance

Second Quarter

  • Net revenues declined 5.4% to $6.3 billion, primarily due to lower net revenues in the smokeable products segment. Revenues net of excise taxes declined 3.7% to approximately $4.9 billion.
  • Reported diluted EPS decreased 3.9% to $0.99, primarily driven by the 2017 gain on the AB InBev/SABMiller business combination, higher investment spending in the innovative tobacco products businesses and lower reported operating companies income (OCI) in the smokeable products segment. These results were partially offset by lower income taxes, higher reported equity earnings from AB InBev (which included AB InBev special items), fewer shares outstanding and higher reported OCI in the smokeless products segment.
  • Adjusted diluted EPSincreased 18.8% to $1.01, primarily driven by lower income taxes and fewer shares outstanding, partially offset by lower adjusted OCI in the smokeable products segment and higher investment spending in the innovative tobacco products businesses.

First Half

  • Net revenues declined 2.6% to $12.4 billion, as lower net revenues in the smokeable products segment were partially offset by higher net revenues in the smokeless products segment. Revenues net of excise taxes declined 1.1% to approximately $9.5 billion.
  • Reported diluted EPS increased 13.7% to $1.99, primarily driven by lower income taxes, higher reported equity earnings from AB InBev (which included AB InBev special items), fewer shares outstanding and higher reported OCI in the smokeless products segment. These results were partially offset by the 2017 gain on the AB InBev/SABMiller business combination, higher investment spending in the innovative tobacco products businesses and lower reported OCI in the smokeable products segment.
  • Adjusted diluted EPSincreased 24.1% to $1.96, primarily driven by lower income taxes, higher adjusted equity earnings from AB InBev, fewer shares outstanding and higher adjusted OCI in the smokeless products segment, partially offset by lower adjusted OCI in the smokeable products segment and higher investment spending in the innovative tobacco products businesses.
Table 1 - Altria’s Adjusted Results    
               
Second Quarter Six Months Ended June 30,
2018 2017   Change 2018 2017 Change
Reported diluted EPS $ 0.99 $ 1.03 (3.9 )% $ 1.99 $ 1.75 13.7 %
NPM Adjustment Items (0.03 ) (0.06 )
Asset impairment, exit and

implementation costs

0.01 0.02
Tobacco and health litigation items 0.03 0.01 0.04 0.01
AB InBev special items (0.03 ) (0.07 ) 0.03
(Gain) loss on AB InBev/SABMiller business combination (0.14 ) 0.01 (0.14 )
Tax items   0.05   (0.06 ) 0.05   (0.09 )
Adjusted diluted EPS   $ 1.01   $ 0.85   18.8

%

  $ 1.96   $ 1.58   24.1 %

Note: For details of pre-tax, tax and after-tax amounts, see Schedules 7 and 9.

Special Items

The EPS impact of the following special items is shown in Table 1 and Schedules 7 and 9.

NPM Adjustment Items

  • In the second quarter of 2018, Altria recorded pre-tax income of $77 million (or $0.03 per share) for an NPM adjustment settlement with Pennsylvania.
  • In the first half of 2018, Altria recorded pre-tax income of $145 million (or $0.06 per share) for NPM adjustment settlements with ten states.

Tobacco & Health Litigation Items

  • In the second quarter and first half of 2018, Altria recorded pre-tax charges of $70 million (or $0.03 per share) and $98 million (or $0.04 per share), respectively, for tobacco and health litigation items and related interest costs.

AB InBev Special Items

  • In the second quarter of 2018, equity earnings from AB InBev included net pre-tax income of $72 million (or $0.03 per share), consisting primarily of gains related to AB InBev’s merger and acquisition activities, partially offset by Altria’s share of AB InBev’s mark-to-market losses on AB InBev’s derivative financial instruments used to hedge certain share commitments.
  • In the first half of 2018, equity earnings from AB InBev included net pre-tax income of $189 million (or $0.07 per share), consisting primarily of Altria’s share of AB InBev’s estimated effect of the Tax Reform Act, and gains related to AB InBev’s merger and acquisition activities, partially offset by Altria’s share of AB InBev’s mark-to-market losses on AB InBev’s derivative financial instruments used to hedge certain share commitments. In the first half of 2017, equity earnings from AB InBev included net pre-tax charges of $75 million (or $0.03 per share), consisting primarily of Altria’s share of AB InBev’s mark-to-market losses on AB InBev’s derivative financial instruments used to hedge certain share commitments.

Gain/(Loss) on AB InBev/SABMiller Business Combination

  • In the first half of 2018, Altria recorded a pre-tax loss of $33 million (or $0.01 per share) related to AB InBev’s divestitures of certain SABMiller assets and businesses in connection with the AB InBev/SABMiller business combination.
  • In the second quarter and first half of 2017, Altria recorded a pre-tax gain of $408 million (or $0.14 per share) related to AB InBev’s divestitures of certain SABMiller assets and businesses in connection with the AB InBev/SABMiller business combination.

Tax Items

  • In the second quarter and first half of 2018, Altria recorded income tax charges of approximately $95 million (or $0.05 per share) primarily related to a tax basis adjustment to Altria’s AB InBev investment and for a valuation allowance on foreign tax credit carryforwards that are not realizable.
  • In the second quarter and first half of 2017, Altria recorded income tax benefits of $108 million (or $0.06 per share) and $166 million (or $0.09 per share), respectively, primarily related to the effective settlement of the 2010-2013 Internal Revenue Service audit.

SMOKEABLE PRODUCTS

Revenues and OCI

Second Quarter

  • Net revenues declined 6.3%, as lower volume was partially offset by higher pricing and lower promotional investments. Revenues net of excise taxes declined 4.8%.
  • Reported OCI declined 1.0%, as lower volume and higher tobacco and health litigation items were partially offset by higher pricing, lower promotional investments and NPM Adjustment Items.
  • Adjusted OCI declined 2.8%, primarily driven by lower volume, partially offset by higher pricing and lower promotional investments. Adjusted OCI marginsincreased 1.1 percentage points to 52.6%.

First Half

  • Net revenues declined 3.7%, as lower volume was partially offset by higher pricing and lower promotional investments. Revenues net of excise taxes declined 2.3%.
  • Reported OCI declined 0.5%, as lower volume, higher costs (including higher tobacco and health litigation items and investments in strategic initiatives) and higher resolution expenses were partially offset by higher pricing, higher NPM Adjustment Items and lower promotional investments.
  • Adjusted OCI declined 2.4%, primarily driven by lower volume, higher costs (including investments in strategic initiatives) and higher resolution expenses, partially offset by higher pricing and lower promotional investments. Adjusted OCI margins were unchanged at 51.2%.
Table 2 - Smokeable Products: Revenues and OCI ($ in millions)  
               
Second Quarter Six Months Ended June 30,
2018 2017   Change 2018 2017 Change
Net revenues $ 5,546 $ 5,922   (6.3 )% $ 10,960 $ 11,380 (3.7 )%
Excise taxes (1,388 ) (1,556 ) (2,789 ) (3,016 )
Revenues net of excise taxes $ 4,158   $ 4,366   (4.8 )% $ 8,171   $ 8,364   (2.3 )%
 
Reported OCI $ 2,201 $ 2,224 (1.0 )% $ 4,239 $ 4,260 (0.5 )%
NPM Adjustment Items (77 ) (145 ) (8 )
Asset impairment, exit, implementation and acquisition-related costs 2 9 3 15
Tobacco and health litigation items 60   15   84   16  
Adjusted OCI $ 2,186   $ 2,248   (2.8 )% $ 4,181   $ 4,283   (2.4 )%
Adjusted OCI margins 1   52.6 % 51.5 %   1.1 pp   51.2 % 51.2 %  

1 Adjusted OCI margins are calculated as adjusted OCI divided by revenues net of excise taxes.

Shipment Volume

Second Quarter

  • Smokeable products segment reported domestic cigarette shipment volumedeclined 10.8%, primarily driven by trade inventory movements, the industry’s rate of decline and retail share losses.
  • When adjusted for trade inventory movements, smokeable products segment domestic cigarette shipment volume decreased by an estimated 5%.
  • Total domestic cigarette industry volumes declined by an estimated 3.5%.
  • Reported cigarshipment volume increased 2.7%.

First Half

  • Smokeable products segment reported domestic cigarette shipment volumedeclined 7.6%, primarily driven by the industry’s rate of decline, trade inventory movements and retail share losses.
  • When adjusted for trade inventory movements, smokeable products segment domestic cigarette shipment volume decreased by an estimated 5.5%.
  • Total domestic cigarette industry volumes declined by an estimated 4.5%.
  • Reported cigarshipment volume increased 2.8%.
Table 3 - Smokeable Products: Shipment Volume (sticks in millions)  
             
Second Quarter Six Months Ended June 30,
2018 2017 Change 2018 2017 Change
Cigarettes:
Marlboro 23,529 26,157 (10.0 )% 47,182 50,852 (7.2 )%
Other premium 1,404 1,550 (9.4 )% 2,813 3,000 (6.2 )%
Discount 2,333   2,862   (18.5 )% 4,793   5,444   (12.0 )%
Total cigarettes 27,266   30,569   (10.8 )% 54,788   59,296   (7.6 )%
 
Cigars:
Black & Mild 414 402 3.0 % 789 765 3.1 %
Other 3   4   (25.0 )% 6   8   (25.0 )%
Total cigars 417   406   2.7 % 795   773   2.8 %
       
Total smokeable products   27,683   30,975   (10.6 )%   55,583   60,069   (7.5 )%

Note: Cigarettes volume includes units sold as well as promotional units, but excludes units sold for distribution to Puerto Rico, and units sold in U.S. Territories, to overseas military and by Philip Morris Duty Free Inc., none of which, individually or in the aggregate, is material to the smokeable products segment.

Retail Share and Brand Activity

IRI refreshed its cigarette database in the first quarter of 2018, which affected previously released retail share results.

Second Quarter

  • Marlboro retail share declined 0.3 share points to 43.2%. Marlboro retail share was stable sequentially from the first quarter.
  • Smokeable products segment total cigarette retail share declined 0.7 share points to 50.2%, and declined 0.1 share point sequentially.
  • Nat Sherman expanded Nat’s into 13 additional states across the western U.S. in mid-June.

First Half

  • Marlboro retail share declined 0.4 share points to 43.2%, driven in part by continued effects from the April 2017 California state excise tax increase.
  • Smokeable products segment total cigarette retail share declined 0.8 share points to 50.2%.
Table 4 - Smokeable Products: Cigarettes Retail Share (percent)  
             
Second Quarter Six Months Ended June 30,
2018 2017

Percentage
point change

2018 2017

Percentage
point change

Cigarettes:
Marlboro 43.2 % 43.5 % (0.3 ) 43.2 % 43.6 % (0.4)
Other premium 2.6 2.7 (0.1 ) 2.6 2.7 (0.1)
Discount 4.4   4.7   (0.3 ) 4.4   4.7   (0.3)
Total cigarettes   50.2 % 50.9 % (0.7 )   50.2 % 51.0 % (0.8)

Note: Retail share results for cigarettes are based on data from IRI/MSAi, a tracking service that uses a sample of stores and certain wholesale shipments to project market share and depict share trends. This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes. For other trade classes selling cigarettes, retail share is based on shipments from wholesalers to retailers (STARS). This service is not designed to capture sales through other channels, including the internet, direct mail and some illicitly tax-advantaged outlets. It is IRI’s standard practice to periodically refresh its services, which could restate retail share results that were previously released in this service.

SMOKELESS PRODUCTS

Revenues and OCI

Second Quarter

  • Net revenues increased 2.7%, primarily driven by higher pricing partially offset by lower volume. Revenues net of excise taxes increased 2.8%.
  • Reported OCI increased 8.6%, primarily driven by higher pricing and lower asset impairment, exit and implementation costs, partially offset by lower volume.
  • Adjusted OCI increased 3.5%, primarily driven by higher pricing partially offset by lower volume. Adjusted OCI margins increased 0.5 percentage points to 69.9%.

First Half

  • Net revenues increased 7.2%, primarily driven by higher pricing and the impact of the 2017 voluntary recall, partially offset by lower volume. Revenues net of excise taxes increased 7.5%.
  • Reported OCI increased 20.6%, primarily driven by higher pricing, the impact of the 2017 voluntary recall and lower asset impairment, exit and implementation costs, partially offset by lower volume.
  • Adjusted OCI increased 13.5%, primarily driven by higher pricing and the impact of the 2017 voluntary recall, partially offset by lower volume. Adjusted OCI margins increased 3.8 percentage points to 69.5%.
Table 5 - Smokeless Products: Revenues and OCI ($ in millions)  
               
Second Quarter Six Months Ended June 30,
2018 2017   Change 2018 2017 Change
Net revenues $ 579 $ 564 2.7 % $ 1,104 $ 1,030 7.2 %
Excise taxes (34 ) (34 ) (66 ) (64 )
Revenues net of excise taxes $ 545   $ 530   2.8 % $ 1,038   $ 966   7.5 %
 
Reported OCI $ 377 $ 347 8.6 % $ 715 $ 593 20.6 %
Asset impairment, exit and implementation costs 4   21   6   42  
Adjusted OCI $ 381   $ 368   3.5 % $ 721   $ 635   13.5 %
Adjusted OCI margins 1   69.9 % 69.4 %   0.5 pp   69.5 % 65.7 % 3.8 pp

1 Adjusted OCI margins are calculated as adjusted OCI divided by revenues net of excise taxes.

Shipment Volume

Second Quarter

  • Smokeless products segment reported domestic shipment volume declined 2.4% primarily driven by the industry’s rate of decline and retail share losses. Adjusted shipment volume comparisons are not provided due to the unusual effects of the 2017 recall.

First Half

  • Smokeless products segment reported domestic shipment volume declined 1.3% primarily driven by the industry’s rate of decline. When adjusted for calendar differences, the smokeless products segment shipment volume declined approximately 1.5%.
  • The smokeless industry volume declined an estimated 1% over the past six months.
Table 6 - Smokeless Products: Shipment Volume (cans and packs in millions)  
             
Second Quarter

Six Months Ended June 30,

2018 2017 Change 2018 2017 Change
Copenhagen 138.1 137.5 0.4 % 262.5 262.0 0.2 %
Skoal 59.8   65.8   (9.1 )% 114.8   121.4   (5.4 )%
Copenhagen and Skoal 197.9 203.3 (2.7 )% 377.3 383.4 (1.6 )%
Other 17.8   17.7   0.6 34.1   33.4   2.1
Total smokeless products   215.7   221.0   (2.4 )%   411.4   416.8   (1.3 )%

Note: Volume includes cans and packs sold, as well as promotional units, but excludes international volume, which is not material to the smokeless products segment. New types of smokeless products, as well as new packaging configurations of existing smokeless products, may or may not be equivalent to existing moist smokeless tobacco (MST) products on a can-for-can basis. To calculate volumes of cans and packs shipped, one pack of snus, irrespective of the number of pouches in the pack, is assumed to be equivalent to one can of MST.

Retail Share and Brand Activity

IRI refreshed its smokeless products database in the first quarter of 2018, which affected previously released retail share results.

Second Quarter

  • Copenhagen retail share was unchanged at 34.3% and Skoal retail share declined 0.4 share points to 16.4%.
  • Copenhagen and Skoal combined retail share decreased 0.4 share points to 50.7%.
  • Smokeless products segment total retail share declined 0.2 share points to 54.1%.

First Half

  • Copenhagen retail share grew 0.5 share points to 34.3% and Skoal retail share declined 0.7 share points to 16.3%.
  • Copenhagen and Skoal combined retail share decreased 0.2 share points to 50.6%.
  • Smokeless products segment total retail share was unchanged at 54.0%.
Table 7 - Smokeless Products: Retail Share (percent)  
             
Second Quarter Six Months Ended June 30,
2018 2017

Percentage
point change

2018 2017

Percentage
point change

Copenhagen 34.3 % 34.3 % 34.3 33.8 % 0.5
Skoal 16.4   16.8   (0.4 ) 16.3   17.0   (0.7 )
Copenhagen and Skoal 50.7 51.1 (0.4 ) 50.6 50.8 (0.2 )
Other 3.4   3.2   0.2   3.4   3.2   0.2  
Total smokeless products   54.1 % 54.3 % (0.2 )   54.0 % 54.0 %  

Note: Retail share results for smokeless products are based on data from IRI InfoScan, a tracking service that uses a sample of stores to project market share and depict share trends. This service tracks sales in the food, drug, mass merchandisers, convenience, military, dollar store and club trade classes on the number of cans and packs sold. Smokeless products is defined by IRI as moist smokeless and spit-free tobacco products. New types of smokeless products, as well as new packaging configurations of existing smokeless products, may or may not be equivalent to existing MST products on a can-for-can basis. For example, one pack of snus, irrespective of the number of pouches in the pack, is assumed to be equivalent to one can of MST. Because this service represents retail share performance only in key trade channels, it should not be considered a precise measurement of actual retail share. It is IRI’s standard practice to periodically refresh its InfoScan services, which could restate retail share results that were previously released in this service.

WINE

Second Quarter

  • Net revenues increased 10.7%, primarily driven by favorable mix and higher shipment volume.
  • Reported and adjusted OCI increased 8.0%, primarily driven by higher volume and favorable mix, partially offset by increased costs.
  • Reported wine shipment volume grew 6.3% to approximately 1.9 million cases.

First Half

  • Net revenues increased 6.2%, primarily driven by higher shipment volume.
  • Reported and adjusted OCI declined 4.3%, primarily driven by higher costs, including one-time employee bonuses, partially offset by higher shipment volume.
  • Reported wine shipment volume grew 6.2% to approximately 3.7 million cases.
Table 8 - Wine: Revenues and OCI ($ in millions)  
             
Second Quarter Six Months Ended June 30,
2018 2017 Change 2018 2017 Change
Net revenues $ 166 $ 150

10.7

%

$ 308 $ 290

6.2

%

Excise taxes (4 ) (5 ) (9 ) (9 )
Revenues net of excise taxes $ 162   $ 145  

11.7

%

$ 299   $ 281  

6.4

%

       
Reported and Adjusted OCI $ 27   $ 25  

8.0

%

$ 44   $ 46  

(4.3

)%

OCI margins 1   16.7 % 17.2 %

(0.5

) pp

  14.7 % 16.4 %

(1.7

) pp

1 OCI margins are calculated as OCI divided by revenues net of excise taxes.

Altria's Profile

Altria’s wholly-owned subsidiaries include Philip Morris USA Inc. (PM USA), U.S. Smokeless Tobacco Company LLC (USSTC), John Middleton Co. (Middleton), Sherman Group Holdings, LLC and its subsidiaries (Nat Sherman), Nu Mark LLC (Nu Mark), Ste. Michelle Wine Estates Ltd. (Ste. Michelle) and Philip Morris Capital Corporation (PMCC). Altria holds an equity investment in Anheuser-Busch InBev SA/NV (AB InBev).

The brand portfolios of Altria’s tobacco operating companies include Marlboro®, Black & Mild®, Copenhagen®, Skoal®, VERVE®, MarkTen®and Green Smoke®. Ste. Michelle produces and markets premium wines sold under various labels, including Chateau Ste. Michelle®, Columbia Crest®, 14 Hands®and Stag’s Leap Wine Cellars, and it imports and markets Antinori®, Champagne Nicolas Feuillatte, Torres®and Villa Maria Estateproducts in the United States. Trademarks and service marks related to Altria referenced in this release are the property of Altria or its subsidiaries or are used with permission. More information about Altria is available at altria.com and on the Altria Investor app.

Basis of Presentation

Altria reports its financial results in accordance with GAAP. Altria’s management reviews OCI, which is defined as operating income before general corporate expenses and amortization of intangibles, to evaluate the performance of, and allocate resources to, the segments. Altria’s management also reviews OCI, OCI margins and diluted EPS on an adjusted basis, which excludes certain income and expense items, including those items noted under “2018 Full-Year Guidance.” Altria’s management does not view any of these special items to be part of Altria’s underlying results as they may be highly variable, may be infrequent, are difficult to predict and can distort underlying business trends and results. Altria’s management also reviews income tax rates on an adjusted basis. Altria’s adjusted effective tax rate may exclude certain tax items from its reported effective tax rate. Altria’s management believes that adjusted financial measures provide useful additional insight into underlying business trends and results and provide a more meaningful comparison of year-over-year results. Altria’s management uses adjusted financial measures for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets. These adjusted financial measures are not consistent with GAAP and may not be calculated the same as similarly titled measures used by other companies. These adjusted financial measures should thus be considered as supplemental in nature and not considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP. Reconciliations of historical adjusted financial measures to corresponding GAAP measures are provided in this release.

Altria uses the equity method of accounting for its investment in AB InBev and reports its share of AB InBev’s results using a one-quarter lag because AB InBev’s results are not available in time to record them in the concurrent period. The one-quarter reporting lag does not affect Altria’s cash flows.

Altria’s reportable segments are smokeable products, including combustible cigarettes and cigars manufactured and sold by PM USA, Middleton and Nat Sherman; smokeless products, including moist smokeless tobacco and snus products manufactured and sold by USSTC; and wine, produced and/or distributed by Ste. Michelle. Results for innovative tobacco products (including Nu Mark’s e-vapor products, VERVE and IQOS) and PMCC are included in “All Other.”

Comparisons are to the corresponding prior-year period unless otherwise stated.

Forward-Looking and Cautionary Statements

This release contains projections of future results and other forward-looking statements that involve a number of risks and uncertainties and are made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995.

Important factors that may cause actual results and outcomes to differ materially from those contained in the projections and forward-looking statements included in this press release are described in Altria’s publicly filed reports, including its Annual Report on Form 10-K for the year ended December 31, 2017 and its Quarterly Report on Form 10-Q for the period ended March 31, 2018. These factors include the following: significant competition; changes in adult consumer preferences and demand for Altria’s operating companies’ products; fluctuations in raw material availability, quality and price; reliance on key facilities and suppliers; reliance on critical information systems, many of which are managed by third-party service providers; fluctuations in levels of customer inventories; the effects of global, national and local economic and market conditions; changes to income tax laws; federal, state and local legislative activity, including actual and potential federal and state excise tax increases; increasing marketing and regulatory restrictions; the effects of price increases related to excise tax increases and concluded tobacco litigation settlements, consumption rates and consumer preferences within price segments; health concerns relating to the use of tobacco products and exposure to environmental tobacco smoke; privately imposed smoking restrictions; and, from time to time, governmental investigations.

Furthermore, the results of Altria’s tobacco businesses are dependent upon their continued ability to promote brand equity successfully; to anticipate and respond to evolving adult consumer preferences; to develop, manufacture, market and distribute products that appeal to adult tobacco consumers (including, where appropriate, through arrangements with, and investments in, third parties); to improve productivity; and to protect or enhance margins through cost savings and price increases.

Altria and its tobacco businesses are also subject to federal, state and local government regulation, including by the FDA. Altria and its subsidiaries continue to be subject to litigation, including risks associated with adverse jury and judicial determinations, courts reaching conclusions at variance with the companies’ understanding of applicable law, bonding requirements in the limited number of jurisdictions that do not limit the dollar amount of appeal bonds and certain challenges to bond cap statutes.

In addition, the factors related to Altria’s investment in AB InBev include the following: the risk that Altria’s equity securities in AB InBev are subject to restrictions on transfer until October 10, 2021; the risk that Altria’s reported earnings from and carrying value of its equity investment in AB InBev and the dividends paid by AB InBev on shares owned by Altria may be adversely affected by unfavorable foreign currency exchange rates and other factors, including the risks encountered by AB InBev in its business; the risk that the tax treatment of Altria’s transaction consideration from the AB InBev/SABMiller business combination and the accounting treatment of its equity investment are not guaranteed; and the risk that the tax treatment of Altria’s investment in AB InBev may not be as favorable as Altria anticipates.

Altria cautions that the foregoing list of important factors is not complete and does not undertake to update any forward-looking statements that it may make except as required by applicable law. All subsequent written and oral forward-looking statements attributable to Altria or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements referenced above.

Schedule 1

ALTRIA GROUP, INC.

and Subsidiaries

Consolidated Statements of Earnings

For the Quarters Ended June 30,

(dollars in millions, except per share data)

(Unaudited)

 
     
2018 2017 % Change
 
Net revenues $ 6,305 $ 6,663 (5.4)%
Cost of sales 1 1,738 1,954
Excise taxes on products 1 1,426   1,595  
Gross profit 3,141 3,114 0.9%
Marketing, administration and research costs 591 514
Asset impairment and exit costs 2   12  
Operating companies income 2,548 2,588 (1.5)%
Amortization of intangibles 5 5
General corporate expenses 45   55  
Operating income 2,498 2,528 (1.2)%
Interest and other debt expense, net 178 177
Net periodic benefit income, excluding service cost (9 ) (11 )
Earnings from equity investment in AB InBev (228 ) (140 )
Gain on AB InBev/SABMiller business combination   (408 )
Earnings before income taxes 2,557 2,910 (12.1)%
Provision for income taxes 680   920  
Net earnings 1,877 1,990 (5.7)%
Net earnings attributable to noncontrolling interests (1 ) (1 )
Net earnings attributable to Altria $ 1,876   $ 1,989   (5.7)%
 
Per share data:
Basic and diluted earnings per share attributable to Altria $ 0.99 $ 1.03 (3.9)%
 
Weighted-average diluted shares outstanding 1,891 1,928 (1.9)%

1 Cost of sales includes charges for resolution expenses related to state settlement agreements and FDA user fees. Supplemental information concerning those items and excise taxes on products sold is shown in Schedule 5.

Note: As a result of the January 1, 2018 adoption of Accounting Standards Update (“ASU”) No. 2017-07, Compensation-Retirement Benefits (Topic 715): Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (“ASU No. 2017-07”), certain immaterial prior-year amounts have been reclassified to conform with the current period’s presentation.

            Schedule 2
ALTRIA GROUP, INC.
and Subsidiaries
Selected Financial Data
For the Quarters Ended June 30,
(dollars in millions)
(Unaudited)
 
 
 
 
 
                     
Net Revenues

Smokeable
Products

 

Smokeless
Products

  Wine   All Other       Total
2018 $ 5,546 $   579 $   166   $   14 $   6,305
2017 5,922 564 150 27 6,663
% Change (6.3 )% 2.7 % 10.7 % (48.1

 

  (5.4 )%
 

Reconciliation:

For the quarter ended June 30, 2017 $ 5,922 $ 564 $ 150 $ 27 $ 6,663
Operations (376 )   15     16       (13

 

      (358 )
For the quarter ended June 30, 2018 $ 5,546     $   579     $   166       $   14       $   6,305  
                     
Operating Companies Income (Loss)

Smokeable
Products

 

Smokeless
Products

  Wine   All Other       Total
2018 $ 2,201 $ 377 $ 27 $ (57

 

$ 2,548
2017 2,224 347 25 (8

 

2,588
% Change (1.0 )% 8.6 % 8.0 % (100.0

 

 

(1.5 )%
 

Reconciliation:

For the quarter ended June 30, 2017 $ 2,224 $ 347 $ 25 $ (8

)

 

$ 2,588
 
Asset impairment, exit, implementation and acquisition-related costs - 2017 9 21 30
Tobacco and health litigation items - 2017 15                     15  
24     21                 45  
 
NPM Adjustment Items - 2018 77 77
Asset impairment, exit and implementation

costs - 2018

(2 ) (4 ) (6 )
Tobacco and health litigation items - 2018 (60 )                   (60 )
15     (4 )               11  
Operations (62 )   13     2       (49

 

      (96 )
For the quarter ended June 30, 2018 $ 2,201     $   377     $   27       $   (57

 

      $   2,548  

Note: As a result of the January 1, 2018 adoption of ASU No. 2017-07, certain immaterial prior-year operating companies income (loss) amounts have been reclassified to conform with the current period’s presentation.

    Schedule 3
ALTRIA GROUP, INC.
and Subsidiaries
Consolidated Statements of Earnings
For the Six Months Ended June 30,
(dollars in millions, except per share data)
(Unaudited)
 
2018 2017 % Change
 
Net revenues $ 12,413 $ 12,746 (2.6)%
Cost of sales 1 3,472 3,767
Excise taxes on products 1 2,864   3,089  
Gross profit 6,077 5,890 3.2%
Marketing, administration and research costs 1,158 996
Asset impairment and exit costs 4   16  
Operating companies income 4,915 4,878 0.8%
Amortization of intangibles 10 10
General corporate expenses 91   101  
Operating income 4,814 4,767 1.0%
Interest and other debt expense, net 344 356
Net periodic benefit income, excluding service cost (16 ) (19 )
Earnings from equity investment in AB InBev (570 ) (163 )
Loss (gain) on AB InBev/SABMiller business combination 33   (408 )
Earnings before income taxes 5,023 5,001 0.4%
Provision for income taxes 1,251   1,609  
Net earnings 3,772 3,392 11.2%
Net earnings attributable to noncontrolling interests (2 ) (2 )
Net earnings attributable to Altria $ 3,770   $ 3,390   11.2%
 
Per share data:
Basic and diluted earnings per share attributable to Altria $ 1.99 $ 1.75 13.7%
 
Weighted-average diluted shares outstanding 1,895 1,933 (2.0)%

1 Cost of sales includes charges for resolution expenses related to state settlement agreements and FDA user fees. Supplemental information concerning those items and excise taxes on products sold is shown in Schedule 5.

Note: As a result of the January 1, 2018 adoption of ASU No. 2017-07, certain immaterial prior-year amounts have been reclassified to conform with the current period’s presentation.

          Schedule 4
ALTRIA GROUP, INC.
and Subsidiaries
Selected Financial Data
For the Six Months Ended June 30,
(dollars in millions)
(Unaudited)
 
 
 
 
 
                   
Net Revenues

Smokeable
Products

 

Smokeless
Products

  Wine   All Other   Total
2018 $ 10,960 $ 1,104 $ 308 $ 41 $ 12,413
2017 11,380 1,030 290 46 12,746
% Change (3.7 )% 7.2 % 6.2 % (10.9 )% (2.6 )%
 

Reconciliation:

For the six months ended June 30, 2017 $ 11,380 $ 1,030 $ 290 $ 46 $ 12,746
Operations (420 )   74     18     (5 )     (333 )
For the six months ended June 30, 2018 $ 10,960     $ 1,104     $ 308     $ 41     $ 12,413  
                   
Operating Companies Income (Loss)

Smokeable
Products

 

Smokeless
Products

  Wine   All Other     Total
2018 $ 4,239 $ 715 $ 44 $ (83 ) $ 4,915
2017 4,260 593 46 (21 ) 4,878
% Change (0.5 )% 20.6 % (4.3 )% (100.0

 

0.8 %
 

Reconciliation:

For the six months ended June 30, 2017 $ 4,260 $ 593 $ 46 $ (21 ) $ 4,878
 
NPM Adjustment Items - 2017 (8 ) (8 )
Asset impairment, exit, implementation and acquisition-related costs - 2017 15 42 57
Tobacco and health litigation items - 2017 16                 16  
23     42             65  
 
NPM Adjustment Items - 2018 145 145
Asset impairment, exit and implementation costs - 2018 (3 ) (6 ) (9 )
Tobacco and health litigation items - 2018 (84 )               (84 )
58     (6 )           52  
Operations (102 )   86     (2 )   (62 )     (80 )
For the six months ended June 30, 2018 $ 4,239     $ 715     $ 44     $ (83 )     $ 4,915  

Note: As a result of the January 1, 2018 adoption of ASU No. 2017-07, certain immaterial prior-year operating companies income (loss) amounts have been reclassified to conform with the current period’s presentation.

    Schedule 5
ALTRIA GROUP, INC.
and Subsidiaries
Supplemental Financial Data
(dollars in millions)
(Unaudited)
 
 

For the Quarters
Ended June 30,

For the Six Months
Ended June 30,

2018 2017 2018 2017
The segment detail of excise taxes on products sold is as follows:
 
Smokeable products $ 1,388 $ 1,556 $ 2,789 $ 3,016
Smokeless products 34 34 66 64
Wine 4   5   9   9
$ 1,426   $ 1,595   $ 2,864   $ 3,089
 
 
The segment detail of charges for resolution expenses related to state settlement agreements included in cost of sales is as follows:
 
Smokeable products $ 961 $ 1,184 $ 1,978 $ 2,264
Smokeless products 2   2   4   4
$ 963   $ 1,186   $ 1,982   $ 2,268
 
 
The segment detail of FDA user fees included in cost of sales is

as follows:

 
Smokeable products $ 72 $ 68 $ 141 $ 136
Smokeless products 1   1   2   2
$ 73   $ 69   $ 143   $ 138
  Schedule 6
ALTRIA GROUP, INC.
and Subsidiaries
Net Earnings and Diluted Earnings Per Share - Attributable to Altria Group, Inc.
For the Quarters Ended June 30,
(dollars in millions, except per share data)
(Unaudited)
 
 
Net Earnings Diluted EPS
2018 Net Earnings $ 1,876 $ 0.99
2017 Net Earnings $ 1,989 $ 1.03
% Change (5.7 )% (3.9 )%
 

Reconciliation:

2017 Net Earnings $ 1,989 $ 1.03
 
2017 Tobacco and health litigation items 11 0.01
2017 AB InBev special items 1
2017 Asset impairment, exit, implementation and acquisition-related costs 17 0.01
2017 Gain on AB InBev/SABMiller business combination (265 ) (0.14 )
2017 Tax items (108 ) (0.06 )
Subtotal 2017 special items (344 ) (0.18 )
 
2018 NPM Adjustment Items 58 0.03
2018 AB InBev special items 57 0.03
2018 Asset impairment, exit and implementation costs (5 )
2018 Tobacco and health litigation items (53 ) (0.03 )
2018 Tax items (94 ) (0.05 )
Subtotal 2018 special items (37 ) (0.02 )
 
Fewer shares outstanding 0.02
Change in tax rate 311 0.16
Operations (43 ) (0.02 )
2018 Net Earnings $ 1,876   $ 0.99  
        Schedule 7
ALTRIA GROUP, INC.
and Subsidiaries
Reconciliation of GAAP and non-GAAP Measures
For the Quarters Ended June 30,
(dollars in millions, except per share data)
(Unaudited)
 
                 

Earnings
before
Income
Taxes

 

Provision
for Income
Taxes

 

Net
Earnings

 

Net Earnings
Attributable to
Altria

 

Diluted
EPS

2018 Reported $ 2,557 $ 680 $ 1,877 $ 1,876   $ 0.99
NPM Adjustment Items (77 ) (19 ) (58 ) (58 ) (0.03 )
AB InBev special items (72 ) (15 ) (57 ) (57 ) (0.03 )
Asset impairment, exit and implementation costs 6 1 5 5
Tobacco and health litigation items 70 17 53 53 0.03
Tax items     (94 )   94     94     0.05  
2018 Adjusted for Special Items $ 2,484     $ 570     $ 1,914     $ 1,913     $ 1.01  
 
2017 Reported $ 2,910 $ 920 $ 1,990 $ 1,989 $ 1.03
Tobacco and health litigation items 17 6 11 11 0.01
AB InBev special items 2 1 1 1
Asset impairment, exit, implementation and acquisition-related costs 30 13 17 17 0.01
Gain on AB InBev/SABMiller business

combination

(408 ) (143 ) (265 ) (265 ) (0.14 )
Tax items     108     (108 )   (108 )   (0.06 )
2017 Adjusted for Special Items $ 2,551     $ 905     $ 1,646     $ 1,645     $ 0.85  
 
2018 Reported Net Earnings $ 1,876 $ 0.99
2017 Reported Net Earnings $ 1,989 $ 1.03
% Change (5.7 )% (3.9 )%
 
2018 Net Earnings Adjusted for Special Items $ 1,913 $ 1.01
2017 Net Earnings Adjusted for Special Items $ 1,645 $ 0.85
% Change 16.3 % 18.8 %
    Schedule 8
ALTRIA GROUP, INC.
and Subsidiaries
Net Earnings and Diluted Earnings Per Share - Attributable to Altria Group, Inc.
For the Six Months Ended June 30,
(dollars in millions, except per share data)
(Unaudited)
 
 
Net Earnings Diluted EPS
2018 Net Earnings $ 3,770 $ 1.99
2017 Net Earnings $ 3,390 $ 1.75
% Change 11.2 % 13.7 %
 

Reconciliation:

2017 Net Earnings $ 3,390 $ 1.75
 
2017 NPM Adjustment Items (1 )
2017 Tobacco and health litigation items 12 0.01
2017 AB InBev special items 49 0.03
2017 Asset impairment, exit, implementation and acquisition-related costs 36 0.02
2017 Gain on AB InBev/SABMiller business combination (265 ) (0.14 )
2017 Tax items (166 ) (0.09 )
Subtotal 2017 special items (335 ) (0.17 )
 
2018 NPM Adjustment Items 109 0.06
2018 Tobacco and health litigation items (73 ) (0.04 )
2018 AB InBev special items 149 0.07
2018 Asset impairment, exit and implementation costs (7 )
2018 Loss on AB InBev/SABMiller business combination (26 ) (0.01 )
2018 Tax items (95 ) (0.05 )
Subtotal 2018 special items 57   0.03  
 
Fewer shares outstanding 0.04
Change in tax rate 604 0.31
Operations 54   0.03  
2018 Net Earnings $ 3,770   $ 1.99  
        Schedule 9
ALTRIA GROUP, INC.
and Subsidiaries
Reconciliation of GAAP and non-GAAP Measures
For the Six Months Ended June 30,
(dollars in millions, except per share data)
(Unaudited)
 
                 

Earnings
before
Income
Taxes

 

Provision
for Income
Taxes

 

Net
Earnings

 

Net Earnings
Attributable to
Altria

 

Diluted
EPS

2018 Reported $ 5,023 $ 1,251 $ 3,772 $ 3,770   $ 1.99
NPM Adjustment Items (145 ) (36 ) (109 ) (109 ) (0.06 )
Tobacco and health litigation items 98 25 73 73 0.04
AB InBev special items (189 ) (40 ) (149 ) (149 ) (0.07 )
Asset impairment, exit and

implementation costs

9 2 7 7
Loss on AB InBev/SABMiller

business combination

33 7 26 26 0.01
Tax items         (95 )     95       95       0.05  
2018 Adjusted for Special Items $ 4,829     $ 1,114     $ 3,715     $ 3,713     $ 1.96  
 
2017 Reported $ 5,001 $ 1,609 $ 3,392 $ 3,390 $ 1.75
NPM Adjustment Items (1 ) (1 ) (1 )
Tobacco and health litigation items 18 6 12 12 0.01
AB InBev special items 75 26 49 49 0.03
Asset impairment, exit, implementation and

acquisition-related costs

60 24 36 36 0.02
Gain on AB InBev/SABMiller business

combination

(408 ) (143 ) (265 ) (265 ) (0.14 )
Tax items         166       (166 )     (166 )     (0.09 )
2017 Adjusted for Special Items $ 4,745     $ 1,688     $ 3,057     $ 3,055     $ 1.58  
 
2018 Reported Net Earnings $ 3,770

$

1.99

2017 Reported Net Earnings $ 3,390 $ 1.75
% Change 11.2 % 13.7 %
 
2018 Net Earnings Adjusted for Special Items $ 3,713

$

1.96

2017 Net Earnings Adjusted for Special Items $ 3,055 $ 1.58
% Change 21.5 % 24.1 %
        Schedule 10
ALTRIA GROUP, INC.
and Subsidiaries
Reconciliation of GAAP and non-GAAP Measures
For the Year Ended December 31, 2017
(dollars in millions, except per share data)
(Unaudited)
 
                 

Earnings
before
Income
Taxes

 

(Benefit)
Provision
for Income
Taxes

 

Net
Earnings

 

Net Earnings
Attributable to
Altria

 

Diluted
EPS

2017 Reported $ 9,828 $ (399 ) $ 10,227 $ 10,222   $ 5.31
NPM Adjustment Items 4 2 2 2
Tobacco and health litigation items 80 30 50 50 0.03
AB InBev special items 160 55 105 105 0.05
Asset impairment, exit, implementation and

acquisition-related costs

89 34 55 55 0.03
Gain on AB InBev/SABMiller business

combination

(445 ) (156 ) (289 ) (289 ) (0.15 )
Settlement charge for lump sum pension payments 81 32 49 49 0.03
Tax items     3,674     (3,674 )   (3,674 )   (1.91 )
2017 Adjusted for Special Items $ 9,797     $ 3,272     $ 6,525     $ 6,520     $ 3.39  
    Schedule 11
ALTRIA GROUP, INC.
and Subsidiaries
Condensed Consolidated Balance Sheets
(dollars in millions)
(Unaudited)
 
June 30, 2018 December 31, 2017

Assets

Cash and cash equivalents $ 1,430 $ 1,253
Inventories 2,123 2,225
Other current assets 578 866
Property, plant and equipment, net 1,878 1,914
Goodwill and other intangible assets, net 17,712 17,707
Investment in AB InBev 18,178 17,952
Finance assets, net 856 899
Other long-term assets 422   386
Total assets $ 43,177   $ 43,202
 

Liabilities and Stockholders’ Equity

Current portion of long-term debt $ 864 $ 864
Accrued settlement charges 2,105 2,442
Other current liabilities 3,419 3,486
Long-term debt 13,036 13,030
Deferred income taxes 5,376 5,247
Accrued postretirement health care costs 1,989 1,987
Accrued pension costs 323 445
Other long-term liabilities 230   283
Total liabilities 27,342 27,784
Redeemable noncontrolling interest 37 38
Total stockholders’ equity 15,798   15,380
Total liabilities and stockholders’ equity $ 43,177   $ 43,202
 
Total debt $ 13,900 $ 13,894

View source version on businesswire.com: https://www.businesswire.com/news/home/20180726005396/en/

(c)Business Wire. All of the news releases contained herein are protected by copyright and other applicable laws, treaties and conventions. Information contained in the releases is furnished by Business Wire's members, who warrant that they are solely responsible for the content, accuracy and originality of the information contained therein. All reproduction, other than for an individual user's personal reference, is prohibited without prior written permission.
}